Testing a combination treatment for high cholesterol
Part of Heart & circulation, Hormones & metabolism clinical trials.
This study tests whether taking two investigational drugs together can safely lower cholesterol in people with primary hypercholesterolemia (a genetic form of high cholesterol). It may help if you have not been able to control your cholesterol with current treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have given your written permission to be in the study.
- You have primary hypercholesterolemia (a condition where your body makes too much cholesterol, often due to genetics).
- You do not have high cholesterol caused by another medical condition (like an underactive thyroid or kidney disease).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new version of a medicine (AD-228B) against the original (AD-2284) to see how they work in the body and if they are safe. Healthy volunteers are needed.
This trial tests a combination of two new medications (AD-227A and AD-227B) to see if they work better together for people with essential (common) high blood pressure. It could be a new treatment option to help control your blood pressure.
This trial tests whether taking two experimental drugs together can safely lower both high blood pressure and high cholesterol. It may be an option if you have both conditions and your blood pressure is not extremely high.
This study tests how two experimental drugs, called AD-236A and AD-236B, interact in the body and checks if they are safe. Healthy volunteers are needed to see how the drugs affect each other.
This trial tests whether three experimental drugs (AD-231A, AD-231B, and AD-231C) interact with each other and how safe they are. Healthy volunteers are needed to help understand how the body processes these drugs.
This early-stage study tests a new investigational drug called AD-231 to see how safe it is and how your body processes it. Researchers will compare it to a combination of three related drugs to understand which approach works best.
Hear when a new Primary Hypercholesterolemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.